Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Department of Urology, Upstate Medical University, Syracuse, New York.
Urol Oncol. 2019 Jun;37(6):356.e1-356.e7. doi: 10.1016/j.urolonc.2019.02.015. Epub 2019 Mar 20.
To study the short and intermediate surgical, renal functional, and oncologic outcomes of multiplex partial nephrectomy (mPN) and standard partial nephrectomy (sPN) in the setting of a solitary kidney.
Review of a prospectively maintained database of patients undergoing solitary kidney partial nephrectomy at our institution was performed. Patients were stratified into 2 cohorts: mPN-where 3 or more renal tumors were resected and sPN-where 1 or 2 tumors were resected. Perioperative, renal functional, and oncological outcomes were compared.
Ninety-three patients with a solitary kidney underwent a total of 121 surgical procedures; 43 (35.5%) were sPN and 78 (64.4%) were mPN. The total and major (Clavien Grade III and IV) complication rates between sPN and mPN were similar (57.1% vs. 70.1%, P = 0.2; 31.0% vs. 35.1%, P = 0.3). At 12 months post-op, the percentage of patients with eGFR > 45 was similar in each group (sPN 87.0%, mPN 73.7%; P = 0.2), and long-term hemodialysis rates were 4.7% and 6.4%, respectively. Completion nephrectomy was performed in 2.3% of sPN and 2.6% of mPN. At a median follow-up of 40.1 months, the metastasis rate was 8.6% in the sPN group and 4.1% in the mPN group (P = 0.4).
Partial nephrectomy in the setting of a solitary kidney can effectively preserve renal function. The renal functional and oncologic outcomes were similar in sPN and mPN, with low hemodialysis rates and complication rates within the expected range of these operations. Three or more tumors in a solitary kidney should not be a contraindication for nephron sparing surgery.
研究在孤立肾中进行多次部分肾切除术(mPN)和标准部分肾切除术(sPN)的短期和中期手术、肾功能和肿瘤学结果。
对我院行孤立肾部分肾切除术患者的前瞻性数据库进行了回顾。患者分为 2 组:mPN-切除 3 个或更多肿瘤,sPN-切除 1 个或 2 个肿瘤。比较围手术期、肾功能和肿瘤学结果。
93 例孤立肾患者共行 121 例手术;43 例(35.5%)为 sPN,78 例(64.4%)为 mPN。sPN 和 mPN 的总并发症发生率和主要并发症发生率(Clavien 分级 III 和 IV)相似(57.1%比 70.1%,P=0.2;31.0%比 35.1%,P=0.3)。术后 12 个月,每组患者的 eGFR>45 的比例相似(sPN 87.0%,mPN 73.7%;P=0.2),长期血液透析率分别为 4.7%和 6.4%。sPN 中有 2.3%和 mPN 中有 2.6%需要行完成性肾切除术。在中位随访 40.1 个月时,sPN 组的转移率为 8.6%,mPN 组为 4.1%(P=0.4)。
孤立肾中的部分肾切除术可有效保护肾功能。sPN 和 mPN 的肾功能和肿瘤学结果相似,血液透析率和并发症发生率均在这些手术的预期范围内。孤立肾中有 3 个或更多肿瘤不应成为保留肾单位手术的禁忌证。